Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Plant Sci ; 11(2): e11514, 2023.
Article in English | MEDLINE | ID: mdl-37051582

ABSTRACT

Premise: Pollen collected by honey bees from different plant species often differs in color, and this has been used as a basis for plant identification. The objective of this study was to develop a new, low-cost protocol to sort pollen pellets by color using high-energy violet light and visible light to determine whether pollen pellet color is associated with variations in plant species identity. Methods and Results: We identified 35 distinct colors and found that 52% of pollen subsamples (n = 200) were dominated by a single taxon. Among these near-pure pellets, only one color consistently represented a single pollen taxon (Asteraceae: Cichorioideae). Across the spectrum of colors spanning yellows, oranges, and browns, similarly colored pollen pellets contained pollen from multiple plant families ranging from two to 13 families per color. Conclusions: Sorting pollen pellets illuminated under high-energy violet light lit from four directions within a custom-made light box aided in distinguishing pellet composition, especially in pellets within the same color.

2.
Sci Rep ; 10(1): 16958, 2020 10 12.
Article in English | MEDLINE | ID: mdl-33046738

ABSTRACT

Pollination services from animals are critical for both crop production and reproduction in wild plant species. Accurately measuring the relative contributions of different animal taxa to pollination service delivery is essential for identifying key pollinators. However, widely used measures of pollinator effectiveness (e.g., single visit pollen deposition) may be inaccurate where plant reproduction is strongly constrained by pollen quality. Here, we test the efficacy of single and multiple pollinator visits for measuring pollinator performance in a model plant species (apple, Malus domestica Borkh) that is strongly limited by pollen quality. We determined pollination success using a suite of measures (pollen deposition, pollen tube growth, fruit and seed set) from single and multiple pollinator visits. We found that pollen deposition from a single pollinator visit seldom resulted in the growth of pollen tubes capable of eliciting ovule fertilisation and never resulted in fruit or seed production. In contrast, multiple pollinator visits frequently initiated the growth of pollen tubes capable of ovule fertilisation and often led to fruit and seed production. Our findings suggest that single visit pollen deposition may provide a poor measure of pollinator performance when linked to reproductive success of plant species that are constrain by pollen quality. Alternatively, pollen tube growth from single and multiple pollinator visits can provide a measure of pollinator performance that is more closely linked to plant reproduction.


Subject(s)
Bees/physiology , Malus/physiology , Pollen Tube/growth & development , Pollen/physiology , Pollination/physiology , Reproduction/physiology , Animals
3.
FEMS Immunol Med Microbiol ; 42(2): 197-204, 2004 Oct 01.
Article in English | MEDLINE | ID: mdl-15364104

ABSTRACT

Bacterial products such as cell walls (CW) and peptidoglycan (PGN) are known to activate macrophages and NK cells during microbial infections. In this report, we demonstrated that whole CW and PGN of four Gram-positive bacteria are capable of enhancing the anti-poxviral activity of murine macrophage RAW 264.7 cells. Among the major Bacillus alcalophilus CW components, PGN contributes the most to antiviral activity and induces remarkably higher levels of IFN-alpha. Anti-IFN-alpha/beta antibody, but not anti-IFN-gamma, anti-IFN-gamma receptor, or anti-IL-12, reversed the PGN-induced inhibition of vaccinia virus replication and reduced nitric oxide (NO) production. Our data thus suggest that PGN induce antiviral activity through IFN-alpha and to a lesser extent, through NO production.


Subject(s)
Antiviral Agents/pharmacology , Bacillus/metabolism , Interferon-alpha/pharmacology , Peptidoglycan/pharmacology , Vaccinia virus/drug effects , Virus Replication/drug effects , Animals , Antiviral Agents/immunology , Antiviral Agents/metabolism , Bacillus/immunology , Cell Line , Interferon-alpha/biosynthesis , Interferon-alpha/immunology , Macrophage Activation , Macrophages/immunology , Macrophages/virology , Mice , Nitric Oxide/biosynthesis , Peptidoglycan/immunology , Vaccinia virus/physiology
4.
FEMS Immunol Med Microbiol ; 40(3): 201-6, 2004 Apr 09.
Article in English | MEDLINE | ID: mdl-15039095

ABSTRACT

The antiviral efficacy of interferons (IFNs) was evaluated using a vaccinia intranasal infection model in mice in this study. We provide evidence that intranasal administration of IFN-alpha and IFN-gamma (days -1 to +3) resulted in 100 and 90% survival against a lethal respiratory vaccinia infection (8 LD50) in mice, respectively; whereas no animals in the placebo group survived through the study period (21 days). The IFN treatment consisted of a single daily dose of 5x10(3) U per mouse for 5 consecutive days. The efficacy of IFN-gamma was evident even when the IFN-gamma treatments started 1-2 days after infection and when a lower dose (2x10(3) U per mouse) was used. The treatment of IFN-alpha and IFN-gamma reduced the virus titers in the lungs of infected mice by 1000-10,000-fold, when the administration started 1 day after infection. Our data suggest that IFN-alpha and IFN-gamma are effective in protecting vaccinia-infected mice from viral replication in lungs and mortality, and may be beneficial in other human orthopoxvirus infections.


Subject(s)
Interferon-alpha/therapeutic use , Interferon-gamma/therapeutic use , Respiratory Tract Infections/prevention & control , Vaccinia/drug therapy , Animals , Antiviral Agents/administration & dosage , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Body Weight , Interferon-alpha/administration & dosage , Interferon-alpha/pharmacology , Interferon-gamma/administration & dosage , Interferon-gamma/pharmacology , Mice , Respiratory Tract Infections/mortality , Survival Analysis , Vaccinia/mortality , Vaccinia/virology , Vaccinia virus/drug effects , Vaccinia virus/growth & development , Viral Plaque Assay , Virus Replication/drug effects
5.
Immunol Lett ; 91(2-3): 171-8, 2004 Feb 15.
Article in English | MEDLINE | ID: mdl-15019287

ABSTRACT

The effects of interleukine-15 (IL-15) on macrophage activation and antiviral activity have been investigated in this study. We have provided evidence that IL-15 stimulates murine macrophage RAW 264.7 cells to release nitric oxide (NO) and inhibit vaccinia virus (VV) replication in bystander human 293 cells in a dose-dependent manner. The IL-15-induced antiviral activity was partially mediated by NO, as blocking NO production by NO synthase (iNOS) inhibitor NG-monomethyl-L-arginine acetate (L-NMA) partially restored the virus replication. Interferon-gamma (IFN-gamma) was not detectable by ELISA in the cell supernatant of IL-15-activated macrophages or in the co-cultures of macrophages and infected bystander cells. Neutralizing anti-IFN-gamma, anti-IFN-gamma receptor R2, anti-TNF-alpha, or anti-IL-12 antibodies had no effect on NO production or antiviral activity. In contrast, neutralizing anti-IFN-alpha/beta antibody completely restored the VV replication and reduced the NO level to one third of that in the control. Elevated mRNA levels of IFN-beta and iNOS genes were detected in IL-15-activated RAW 264.7 cells by RT-PCR. Our data suggest that IL-15 is capable of inducing IFN-beta, which could participate in NO-mediated antiviral effect.


Subject(s)
Gene Expression Regulation/drug effects , Interferon-beta/genetics , Interleukin-15/pharmacology , Macrophages/drug effects , Macrophages/immunology , Nitric Oxide Synthase/genetics , Animals , Bystander Effect/drug effects , Cell Line , Humans , Interferon-beta/analysis , Interferon-beta/antagonists & inhibitors , Interferon-beta/immunology , Interferon-gamma/analysis , Interferon-gamma/genetics , Interferon-gamma/pharmacology , Macrophages/enzymology , Macrophages/metabolism , Mice , Nitric Oxide Synthase Type II , Nitrogen Oxides/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription, Genetic/drug effects , Tumor Necrosis Factor-alpha/metabolism , Vaccinia virus/immunology , Vaccinia virus/physiology , Virus Replication/drug effects , omega-N-Methylarginine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...